To further confirm the anti-tumor immune escape function of IFNAR1, we performed multiplex immunohistochemistry on 30 pairs of ccRCC and para-tumor tissues to observe the expression of IFNAR1 in different types of cells in the tissues (Quantification results were listed in Table S2). This evidence concerns the gene IFNAR1 and nonpapillary renal cell carcinoma.